Therapeutic cell carriers: A potential road to cure glioma

Jacob S. Young, Julius W. Kim, Atique U. Ahmed, Maciej S. Lesniak*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations


Many different experimental molecular therapeutic approaches have been evaluated in an attempt to treat brain cancer. However, despite the success of these experimental molecular therapies, research has shown that the specific and efficient delivery of therapeutic agents to tumor cells is a limitation. In this regard, cell carrier systems have garnered significant attraction due to their capacity to be loaded with therapeutic agents and carry them specifically to tumor sites. Furthermore, cell carriers can be genetically modified to express therapeutic agents that can directly eradicate cancerous cells or can modulate tumor microenvironments. This review describes the current state of cell carriers, their use as vehicles for the delivery of therapeutic agents to brain tumors, and future directions that will help overcome the present obstacles to cell carrier mediated therapy for brain cancer.

Original languageEnglish (US)
Pages (from-to)651-660
Number of pages10
JournalExpert Review of Neurotherapeutics
Issue number6
StatePublished - Jun 2014


  • brain cancer
  • cell carriers
  • gene therapy
  • glioblastoma multiforme
  • glioma
  • induced progenitor cells
  • mesenchymal stem cells
  • neural stem cells
  • oncolytic virotherapy
  • tumor-tropism

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Therapeutic cell carriers: A potential road to cure glioma'. Together they form a unique fingerprint.

Cite this